Literature DB >> 3490491

High production of the acquired immunodeficiency syndrome virus (lymphadenopathy-associated virus) by human T lymphocytes stimulated by streptococcal mitogenic toxins.

J E Alouf, C Geoffroy, D Klatzmann, J C Gluckman, J Gruest, L Montagnier.   

Abstract

Purified streptococcal mitogens (SMs) including erythrogenic exotoxin were compared with phytohemagglutinin (PHA) for their ability to sustain lymphadenopathy-associated virus (LAV) replication after the stimulation of normal human peripheral blood mononuclear cells and purified CD4+ and CD8+ T cells infected with LAV. Both SM and PHA supported LAV production in peripheral blood mononuclear and CD4+ cells but not in CD8+ cells. LAV production assessed by the assay of reverse transcriptase in cell supernatants appeared earlier after stimulation with SM and was 6- to 10-fold greater than after stimulation by PHA.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3490491      PMCID： PMC268988          DOI： 10.1128/jcm.24.4.639-641.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Polyclonal antibody-forming cell activation and immunomodulation of the in vitro immune response induced by streptococcal extracellular products.

Authors:  J M Cavaillon; C Leclerc; J E Alouf
Journal:  Cell Immunol       Date:  1983-02-15       Impact factor: 4.868

2.  Functional and immunological characterization of the stimulation of human lymphocytes with a mitogen from group A streptococci (SM).

Authors:  F Quagliata; S Beckerdite Quagliata; R A Alsobrook; C Russo; F Indiveri; M A Pellegrino; S Ferrone
Journal:  Cell Immunol       Date:  1982-03-15       Impact factor: 4.868

3.  Induction of interferon by streptococcus pyogenes extracellular products.

Authors:  J M Cavaillon; Y Riviere; J Svab; L Montagnier; J E Alouf
Journal:  Immunol Lett       Date:  1982       Impact factor: 3.685

4.  Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A.

Authors:  J M Cavaillon; J E Alouf
Journal:  Immunol Lett       Date:  1982       Impact factor: 3.685

5.  Characterization of the human cellular immune response to purified group A streptococcal blastogen A1.

Authors:  W E Regelmann; E D Gray; L W Wannamaker
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

Review 6.  Immunologic abnormalities in the acquired immunodeficiency syndrome.

Authors:  H C Lane; A S Fauci
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

7.  Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins.

Authors:  E L Barsumian; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

10.  Suppression of lymphocyte reactivity by blood transfusions in uremic patients. I. Proliferative responses.

Authors:  D Klatzmann; J C Gluckman; C Foucault; A Bensussan; U Assobga; A Duboust
Journal:  Transplantation       Date:  1983-04       Impact factor: 4.939
View more
  4 in total

1.  Benign monoclonal expansion of CD8+ lymphocytes in HIV infection.

Authors:  P R Smith; J D Cavenagh; T Milne; D Howe; S J Wilkes; P Sinnott; G E Forster; M Helbert
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

2.  Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic fever.

Authors:  G M Bahr; A M Yousof; K Behbehani; H A Majeed; S Sakkalah; K Souan; I Jarrad; C Geoffroy; J E Alouf
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

3.  Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide.

Authors:  H Müller-Alouf; J E Alouf; D Gerlach; J H Ozegowski; C Fitting; J M Cavaillon
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

4.  Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro.

Authors:  Alex Olvera; Javier P Martinez; Maria Casadellà; Anuska Llano; Míriam Rosás; Beatriz Mothe; Marta Ruiz-Riol; Gemma Arsequell; Gregorio Valencia; Marc Noguera-Julian; Roger Paredes; Andreas Meyerhans; Christian Brander
Journal:  Front Immunol       Date:  2018-01-26       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.